The Changing Global Epidemic of HIV and Ocular Disease

References

• Marsh K, Eaton JW, Mahy M, et al. Global, regional and country-level 90- 90-90estimates for 2018: assessing progress towards the 2020 target. AIDS. 2019;33(Suppl 3):S213–226. doi:10.1097/QAD.0000000000002355.
   PubMedGoogle Scholar
• Porter K, Gourlay A, Attawell K, et al. Substantial heterogeneity in progress toward reaching the 90- 90-90HIV target in the WHO European Region. J Acquir Immune Defic Syndr. 2018;79(1):28–35. doi:10.1097/QAI.0000000000001761.
   PubMed Web of Science ®Google Scholar
• Lilian RR, Rees K, Mabitsi M, McIntyre JA, Struthers HE, Peters RPH. Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: analysis of routine data. South Afr J HIV Med. 2019;20(1):963. doi:10.4102/sajhivmed.v20i1.963.
   PubMedGoogle Scholar
• INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. New Engl J Med. 2015;373(9):795–807. doi:10.1056/NEJMoa1506816.
   PubMed Web of Science ®Google Scholar
• Zürcher K, Mooser A, Anderegg N, et al. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health. 2017;22(4):375–387. doi:10.1111/tmi.12843.
   PubMed Web of Science ®Google Scholar
• Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561–570. doi:10.1097/00001648-200009000-00012.
   PubMed Web of Science ®Google Scholar
• Vella S, Schwartländer B, Sow SP, Eholie SP, Murphy RL. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS. 2012;26(10):1231–1241. doi:10.1097/QAD.0b013e32835521a3.
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018;293(10148):685–697. doi:10.1016/S0140-6736(18)31311-4.
   Google Scholar
• Schaftenaar E, van Gorp EC, Meenken C, et al. Ocular infections in sub-Saharan Africa in the context of high HIV prevalence. Trop Med Int Health. 2014;19(9):1003–1014. doi:10.1111/tmi.12350.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618. doi:10.1136/bjophthalmol-2011-300539.
   PubMed Web of Science ®Google Scholar
• Evans TG. Socioeconomic consequences of blinding onchocerciasis in West Africa. Bull World Health Organ. 1995;73:495–506.
   PubMed Web of Science ®Google Scholar
• Köberlein J, Beifus K, Schaffert C, Finger RP. The economic burden of visual impairment and blindness: a systematic review. BMJ Open. 2013;3:e003471. doi:10.1136/bmjopen-2013-003471.
   PubMed Web of Science ®Google Scholar
• Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221–34. doi:10.1016/S2214-109X(17)30393-5.
   PubMed Web of Science ®Google Scholar
• Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness. Bull World Health Organ. 2001;79:208–213.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339(4):236–244. doi:10.1056/NEJM199807233390406.
   PubMed Web of Science ®Google Scholar
• Pathai S, Deshpande A, Gilbert C, Lawn SD. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. BMC Ophthalmol. 2009;9:158.
   Google Scholar
• Kestelyn P, Lepage P, Karita E. van de Perre P. Ocular manifestations of infection with the human immunodeficiency virus in an African paediatric population. Ocul Immunol Inflamm. 2000;8(4):263–273. doi:10.1076/ocii.8.4.263.6455.
   PubMed Web of Science ®Google Scholar
• Shah SU, Kerkar SP, Pazare AR. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in Western India. Br J Ophthalmol. 2009;93(1):88–90. doi:10.1136/bjo.2008.149237.
   PubMed Web of Science ®Google Scholar
• Ganekal S, Jhanji V, Dorairaj S, Nagarajappa A. Evaluation of ocular manifestions and blindness in HIV/AIDS patients in a tertiary care hospital in South India. Ocul Immunol Inflamm. 2012;20(5):336–341. doi:10.3109/09273948.2012.699133.
   PubMed Web of Science ®Google Scholar
• Abu EK, Abokyi S, Oribi-Yeboah D, et al. Retinal microvasculopathy is common in HIV/AIDS Patients: a cross-sectional study at the Cape Coast Teaching Hospital, Ghana. J Ophthalmol. 2016;2016:8614095. doi:10.1155/2016/8614095.
   PubMed Web of Science ®Google Scholar
• Luo J, Jing D, Kozak I, et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol. 2013;20(3):170–175. doi:10.3109/09286586.2013.789530.
   PubMed Web of Science ®Google Scholar
• Bekele S, Gelaw Y, Tessema F. Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma Town, Ethiopia: a cross-sectional study. BMC Ophthalmol. 2013;13:20. doi:10.1186/1471-2415-13-20.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park SJ, Yu HG, Kim NJ, Jang HC, Oh MD. Ocular manifestations of acquired immunodeficiency syndrome in Korea. J Korean Med Sci. 2012;27(5):542–546. doi:10.3346/jkms.2012.27.5.542.
   PubMed Web of Science ®Google Scholar
• Singlavanija T, Ausayakhun S, Tangmonkongvoragul C. Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive study. PLoS One. 2018;13(2):e0193161. doi:10.1371/journal.pone.0193161.
   PubMed Web of Science ®Google Scholar
• Saini N, Hasija S, Kaur P, Kaur M, Pathania V, Singh A. Study of prevalence of ocular manifestations in HIV positive patients. Nepal J Ophthalmol. 2019;11:11–18. doi:10.3126/nepjoph.v11i1.25411.
   PubMed Web of Science ®Google Scholar
• Kaleem MA, Ramsahai S, Del Fierro K, et al. Ocular findings in human immunodeficiency virus patients in Washington, DC. Int Ophthalmol. 2012;32(2):145–151. doi:10.1007/s10792-012-9543-3.
   PubMed Web of Science ®Google Scholar
• Akçakaya AA, Sargin F, Erbil HH, et al. HIV-related eye disease in patients presenting to a tertiary government hospital in Turkey. Ocul Immunol Inflamm. 2012;20(3):158–162. doi:10.3109/09273948.2012.676701.
   PubMed Web of Science ®Google Scholar
• Martin-Odoom BEY, Opoku DK. Ocular complications in HIV-positive patients on antiretroviral therapy in Ghana. BMC Ophthalmol. 2016;16:134. doi:10.1186/s12886-016-0310-5.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jia R, Ge S, et al. Ocular complications of human immunodeficiency virus infection in eastern China. Am J Ophthalmol. 2012;153(2):363–369. doi:10.1016/j.ajo.2011.07.018.
   PubMed Web of Science ®Google Scholar
• Lestari YD, Sitompul R, Edwar L, Djoerban Z. Ocular diseases among HIV/AIDS patients in Jakarta, Indonesia. Southeast Asian J Trop Med Public Health. 2013;44:62–71.
   PubMed Web of Science ®Google Scholar
• Freeman WR, Chen A, Henderly DE, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989;107:229–235. doi:10.1016/0002-9394(89)90304-8.
   PubMed Web of Science ®Google Scholar
• Otiti-Sengeri J, Meenken C, van den Horn GJ, Kempen JH. Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS. 2008;3:432–437. doi:10.1097/COH.0b013e328302cc3d.
   PubMed Web of Science ®Google Scholar
• Karavellas MP, Plummer DJ, MacDonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of highly active antiretroviral therapy. J Infect Dis. 1999;179:697–700. doi:10.1086/314639.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Min YI, Freeman WR, et al. Studies of ocular complications of AIDS Research Group. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113(4):684–694. doi:10.1016/j.ophtha.2005.10.067.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Butler KM, Pizzo PA, Nussenblatt RB. Retinal lesions in children treated with dideoxyinosine. N Engl J Med. 1992;326:1226–1227.
   PubMed Web of Science ®Google Scholar
• Miller C, Short WR, Perez-Povis L, et al. The spectrum of eye disease in hospitalized adults living with HIV, 1995-2010. AIDS Patient Care STDS. 2014;28(2):47–55. doi:10.1089/apc.2013.0258.
   PubMed Web of Science ®Google Scholar
• Jabs DA, van Natta ML, Holbrook JT, et al. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007;114(4):780–786. doi:10.1016/j.ophtha.2006.11.008.
   PubMed Web of Science ®Google Scholar
• Kahraman G, Krepler K, Franz C, et al. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Ocul Immunol Inflamm. 2005;13(2):213–218. doi:10.1080/09273940490912443.
   PubMed Web of Science ®Google Scholar
• Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA. Wohrmann et al. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection. 2005;33(5–6):345–349. doi:10.1007/s15010-005-5050-z.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pirraglia MP, Corradi R, Corsi C, Fabiani C, Pivetti-Pezzi P. Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. Eur J Ophthalmol. 2006;16(5):728–732. doi:10.1177/112067210601600511.
   PubMed Web of Science ®Google Scholar
• Sun HY, Peng XY, Li D, Mao FF, You QS, Jonas JB. Cytomegalovirus retinitis in patients with AIDS before and after introduction of HAART in China. Eur J Ophthalmol. 2014;24(2):209–215. doi:10.5301/ejo.5000354.
   PubMed Web of Science ®Google Scholar
• Esposito S, Porta A, Bojanin J, et al. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children. Eye. 2006;20:595–597. doi:10.1038/sj.eye.6702189.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Singh R, Sharma A, Gupta V, Dogra MR. Ocular manifestations in patients with immunodeficiency virus infection in the Pre-HAART versus the HAART era in the North Indian population. Ocul Immunol Inflamm. 2017;25(3):396–404. doi:10.3109/09273948.2015.1133837.
   PubMed Web of Science ®Google Scholar
• Schaftenaar E, Khosa NS, Baarsma GS, et al. HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease. Epidemiol Infect. 2017;145(12):2520–2529. doi:10.1017/S0950268817000978.
   PubMed Web of Science ®Google Scholar
• Cohen J, Torres C. HIV-associated cellular senescence: a contributor to accelerated ageing. Ageing Res Rev. 2017;36:117–124. doi:10.1016/j.arr.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Kestelyn P, Taelman H, Bogaerts J, et al. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immune deficiency syndrome. Am J Ophthalmol. 1993;116:721–727. doi:10.1016/S0002-9394(14)73472-5.
   PubMed Web of Science ®Google Scholar
• Andreola C, Ribeiro MP, de Carli CR, Gouvea AL, Curi AL. Multifocal choroiditis in disseminated Cryptococcus neoformans infection. Am J Ophthalmol. 2006;142(2):346–348. doi:10.1016/j.ajo.2006.03.024.
   PubMed Web of Science ®Google Scholar
• Babu K, Murthy KR, Rajagopalan N. Primary bilateral multifocal choroiditis as an initial manifestation of disseminated cryptococcosis in a HIV-positive patient. Ocul Immunol Inflamm. 2008;16(4):191–193. doi:10.1080/09273940802204568.
   PubMed Web of Science ®Google Scholar
• Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. Biomed Res Int. 2015;2015:164989. doi:10.1155/2015/164989.
   PubMed Web of Science ®Google Scholar
• Nookeu P, Angkasekwinai N, Foongladda S, Phoompoung P. Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum. Emerg Infect Dis. 2019;25(9):1648–1652. doi:10.3201/eid2509.190430.
   PubMed Web of Science ®Google Scholar
• Hodge WG, Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study. Ophthalmology. 1997;104(1):120–124. doi:10.1016/S0161-6420(97)30351-0.
   PubMed Web of Science ®Google Scholar
• Schaftenaar E, Peters RP, Baarsma GS, et al. Clinical and corneal microbiological profile of infectious keratitis in a high HIV prevalence setting in South Africa. Eur J Clin Microbiol Infect Dis. 2016;35(9):1403–1409. doi:10.1007/s10096-016-2677-x.
   PubMed Web of Science ®Google Scholar
• Schaftenaar E, Meenken C, Baarsma GS, McIntyre JA, Verjans GM, Peters RP. Early- and late-stage complications of herpes zoster ophthalmicus in rural South Africa. Trop Med Int Health. 2016;21(3):334–339. doi:10.1111/tmi.12654.
   PubMed Web of Science ®Google Scholar
• Wells JM, Smith JR. Uveitis in human immunodeficiency virus-infected individuals. Int Ophthalmol Clin. 2015;55(2):11–18. doi:10.1097/IIO.0000000000000061.
   PubMedGoogle Scholar
• London NJ, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50(2):1–17. doi:10.1097/IIO.0b013e3181d2cc6b.
   PubMedGoogle Scholar
• Schaftenaar E, Meenken C, Baarsma GS, et al. Uveitis is predominantly of infectious origin in a high HIV and TB prevalence setting in rural South Africa. Br J Ophthalmol. 2016;100(10):1312–1316. doi:10.1136/bjophthalmol-2016-308645.
   PubMed Web of Science ®Google Scholar
• Nirwoth JP, Hall AB, Lewallen S. Prevalence of cytomegalovirus retinitis in Tanzanians with low CD4 levels. Br J Ophthalmol. 2011;95(4):460–462. doi:10.1136/bjo.2010.186965.
   PubMed Web of Science ®Google Scholar
• Beare NA, Kublin JG, Lewis DK, et al. Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa. Br J Ophthalmol. 2002;86(10):1076–1079. doi:10.1136/bjo.86.10.1076.
   PubMed Web of Science ®Google Scholar
• Kestelyn P. The epidemiology of CMV retinitis in Africa. Ocul Immunol Inflamm. 1999;7:173–177. doi:10.1076/ocii.7.3.173.4002.
   PubMed Web of Science ®Google Scholar
• Heiden D, Saranchuk P, Keenan JD, et al. Eye examination for early diagnosis of disseminated tuberculosis in patients with AIDS. Lancet Infect Dis. 2016;16(4):493–499. doi:10.1016/S1473-3099(15)00269-8.
   PubMed Web of Science ®Google Scholar
• Basavaraju A. Toxoplasmosis in HIV: an overview. Trop Parasitol. 2016;6(2):129–135. doi:10.4103/2229-5070.190817.
   PubMedGoogle Scholar
• Tsuboi M, Nishijima T, Yashiro S, et al. Time to development of ocular syphilis after syphilis infection. J Infect Chemother. 2018;24(1):75–77. doi:10.1016/j.jiac.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Pratas AC, Goldschmidt P, Lebeaux D, et al. Increase in ocular syphilis cases at ophthalmologic reference center, France, 2012-2015. Emerg Infect Dis. 2018;24(2):193–200. doi:10.3201/eid2402.171167.
   PubMed Web of Science ®Google Scholar
• Cope AB, Mobley VL, Oliver SE, et al. Ocular syphilis and human immunodeficiency virus coinfection among syphilis patients in North Caroline, 2014-2016. Sex Transm Dis. 2019;46(2):80–85. doi:10.1097/OLQ.0000000000000910.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn JC, Ranoto L, Muditambi N, et al. Reduction in extrapulmonary tuberculosis in the context of antiretroviral therapy scale-up in rural South Africa. Epidemiol Infect. 2017;145:2500–2509. doi:10.1017/S095026881700156X.
   PubMed Web of Science ®Google Scholar
• Furtado JM, Arantes TE, Nascimento H, et al. Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of systemic infection. Sci Rep. 2018;8(1):12071. doi:10.1038/s41598-018-30559-7.
   PubMedGoogle Scholar
• Gichuhi S, Sagoo MS, Wiess HA, Burton MJ. Epidemiology of ocular squamous cell neoplasia in Africa. Trop Med Int Health. 2013;18(12):1424–1443. doi:10.1111/tmi.12203.
   PubMed Web of Science ®Google Scholar
• Hämmerl L, Ferlay J, Borok M, Carrilho C, Parkin DM. The burden of squamous cell carcinoma of the conjunctiva in Africa. Cancer Epidemiol. 2019;61:150–153. doi:10.1016/j.canep.2019.06.007.
   PubMed Web of Science ®Google Scholar
• Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, et al. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer. 2010;102(2):262–267. doi:10.1038/sj.bjc.6605466.
   PubMed Web of Science ®Google Scholar
• Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM. Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer. 2008;122(11):2590–2593. doi:10.1002/ijc.23384.
   PubMed Web of Science ®Google Scholar
• Simbiri KO, Murakami M, Feldman M, et al. Multiple oncogenic viruses identified in ocular surface squamous neoplasia in HIV-1 infected patients. Infect Agent Cancer. 2010;5:6. doi:10.1186/1750-9378-5-6.
   PubMedGoogle Scholar
• White DL, Oluyomi A, Royse K, et al. Incidence of AIDS-related Kaposi sarcoma in all 50 United States from 2000 to 2014. J Acquir Immune Defic Syndr. 2019;181(4):387–394. doi:10.1097/QAI.0000000000002050.
   Google Scholar
• Agarwal A, Invernizzi A, Jain S, et al. Choroidal thickness in patients diagnosed with human immunodeficiency virus infection: results from two populations of different ethnicities. Ocul Immunol Inflamm. 2019;27:560–566. doi:10.1080/09273948.2018.1439970.
   PubMed Web of Science ®Google Scholar
• Xie LY, Chen C, Kong WJ, Du KF, Guo CG, Wei WB. A comparative study on retinal thickness of the macular region among AIDS patients with normal ocular fundus, HIV-related microvacular retinopathy patients, and cytomegalovirus retinitis patients. Medicine (Baltimore). 2019;98(26):e16073. doi:10.1097/MD.0000000000016073.
   PubMed Web of Science ®Google Scholar
• Chen C, Guo CG, Meng L, et al. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. Int J Ophthalmol. 2017;10:1396–1401. doi:10.18240/ijo.2017.09.11.
   PubMed Web of Science ®Google Scholar
• Furrer H, Barloggio A, Egger M, Garweg JG. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma. Ophthalmol. 2003;110(2):432–436. doi:10.1016/S0161-6420(02)01750-5.
   PubMed Web of Science ®Google Scholar
• Mwanza JC, Nyamabo LK, Tylleskar T, Plant GT. Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations. Br J Ophthalmol. 2004;88(11):1455–1459. doi:10.1136/bjo.2004.044289.
   PubMed Web of Science ®Google Scholar
• Mansour AM. Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J Clin Neuroophthalmol. 1990;10:167–174.
   PubMedGoogle Scholar
• Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264–271. doi:10.1080/09286580802077716.
   PubMed Web of Science ®Google Scholar
• Laurent-Coriat C, Tilikete C, Bouhour D, Boulliat J, Fleury J, Metal B. HIV infection presenting with bilateral optic neuropathy. Rev Neurol(Paris). 2006;162:95–97. doi:10.1016/S0035-3787(06)74988-8.
   PubMed Web of Science ®Google Scholar
• Mowatt L. Ophthalmic manifestations of HIV in the highly active antiretroviral therapy era. West Indian Med J. 2013;62:305–312. doi:10.7727/wimj.2013.210.
   PubMed Web of Science ®Google Scholar
• Ashraf DC, May KP, Holland GN, et al. Studies of the Ocular Complications of AIDS Research Group. Ophthalmology. 2015;122:2560–2567. doi:10.1016/j.ophtha.2015.07.037.
   PubMedGoogle Scholar
• Demirkaya N, Wit F, Schlingemann R, Verbraak F. Neuroretinal degeneration in HIV patients without opportunistic ocular infections in the cART era. AIDS Patient Care STDs. 2015;29:519–532. doi:10.1089/apc.2015.0091.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Drye L, Van Natta ML, Thorne JE, Holland GN. Incidence and long-term outcomes of the human immunodeficiency virus neuroretinal disorder in patients with AIDS. Ophthalmology. 2015;122:760–768. doi:10.1016/j.ophtha.2014.11.009.
   PubMed Web of Science ®Google Scholar
• Ivernizzi A, Acquistapace A, Bochicchio S, et al. Correlation between inner retinal layer thickness and cognitive function in HIV: new insights from an exploratory study. AIDS. 2018;32(11):1485–1490. doi:10.1097/QAD.0000000000001850.
   PubMed Web of Science ®Google Scholar
• Schaftenaar E, Meenken C, Baarsma GS, Verjans GM, Peters RP. Good visual outcome of tuberculous chorioretinitis after ART initiation in an HIV-infected patient. Int Ophthalmol. 2014;34(6):1263–1265. doi:10.1007/s10792-014-9997-6.
   PubMed Web of Science ®Google Scholar
• Khurana RN, Javaheri M, Rao N. Ophthalmic manifestations of immune reconstitution inflammatory syndrome associated with Cryptococcus neoformans. Ocul Immunol Inflamm. 2008;16(4):185–190. doi:10.1080/09273940802204550.
   PubMed Web of Science ®Google Scholar
• Jabs DA, van Natta DL, Holland GN, Danis R; Studies of the Ocular Complications of AIDS Research Group. Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome after initiating antiretroviral therapy. Am J Ophthalmol. 2017;174:23–32. doi:10.1016/j.ajo.2016.10.011.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis. 2003;37(10):1365–1373. doi:10.1086/379077.
   PubMed Web of Science ®Google Scholar
• Gabrielian A, MacCumber MM, Kukuyev A, Mitsuyasu R, Holland GN, Sarraf D. Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus. JAMA Ophthalmol. 2013;131(2):255–259. doi:10.1001/jamaophthalmol.2013.579.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Butler KM, Caruso R, de Smet MD, Rubin B, Husson RN. Retinal toxicity in human immunodeficiency virus-infected children treated with 2ʹ,3ʹ-dideoxyinosine. Am J Ophthalmol. 1992;113(1):1–7. doi:10.1016/S0002-9394(14)75744-7.
   PubMed Web of Science ®Google Scholar
• Riva A, Invernizzi A, Resnati C, Micheli V, Cattaneo D, Gervasconi C. Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? Antivir Ther. 2017;22(5):453–455. doi:10.3851/IMP3058.
   PubMed Web of Science ®Google Scholar
• Song W., Si S. The rare ethambutol-induced optic neuropathy: a case-report and literature review. Medicine (Baltimore). 2017;96(2):e5889. doi:10.1097/MD.0000000000005889.
   PubMed Web of Science ®Google Scholar
• Mehta S, Das M, Laxmeshwar C, Jonckheere S, Thi SS, Isaakidis P. Linezolid-associated optic neuropathy in drug-resistant tuberculosis patients in Mumbai, India. PLoS One. 2016;11(9):e0162138. doi:10.1371/journal.pone.0162138.
   PubMed Web of Science ®Google Scholar
• Akler ME, Johsnon DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105:651–657. doi:10.1016/S0161-6420(98)94019-2.
   PubMed Web of Science ®Google Scholar
• Taskintuna I, Rahhal FM, Rao NA, et al. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). Ophthalmology. 1997;104:1827–1836. doi:10.1016/S0161-6420(97)30020-7.
   PubMed Web of Science ®Google Scholar
• Pathai S, Lawn SD, Weiss HA, Cook C, Bekker LG, Gilbert CE. Increased ocular lens density in HIV-infected individuals with low nadir CD4 counts in South Africa: evidence of accelerated ageing. J Acquir Immune Defic Syndr. 2013;63(3):307–314. doi:10.1097/QAI.0b013e31828ad759.
   PubMed Web of Science ®Google Scholar
• Otiti-Sengeri J, Colebunders R, Kempen JH, Ronald A, Sande M, Katabira E. The prevalence and causes of visual loss among HIV-infected individuals in Uganda. J Acquir Immune Defic Syndr. 2010;53(1):95–101. doi:10.1097/QAI.0b013e3181c313f0.
   PubMed Web of Science ®Google Scholar
• Rasmussen LD, Kessel L, Molander LD, et al. Risk of cataract surgery in HIV-infected individuals: a Danish nationwide population-based cohort study. Clin Infect Dis 2011; 53(11):1156-63.Otiti-Sengeri J, Colebunders R, Reynolds SJ, Muwonge M, Nakigozi C, Kiggundu V, et al. Elevated inflammatory cytokines in aqueous cytokine profile in HIV-infected patients with cataracts in Uganda. BMC Ophthalmol. 2018;18(1):12.
   PubMedGoogle Scholar
• Otiti-Sengeri J, Colebunders R, Reynolds SJ, et al. Elevated inflammatory cytokines in aqueous cytokine profile in HIV-infected patients with cataracts in Uganda. BMC Ophthalmol. 2018;18(1):12. doi:10.1186/s12886-018-0680-y.
   PubMedGoogle Scholar
• Accorinti M, Cecere M, Scala A, Pirraglia MP. Cataract surgery in HIV seropositive patients: long-term follow-up. Ocul Immunol Inflamm. 2019;27(3):435–446. doi:10.1080/09273948.2017.1416149.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Ahuja A, Van Natta M, et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology. 2010;117:2152–2161. doi:10.1016/j.ophtha.2010.03.031.
   PubMed Web of Science ®Google Scholar
• Sugar EA, Jabs DA, Ahuja A, et al. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012;153:1024–1026. doi:10.1016/j.ajo.2011.11.014.
   Web of Science ®Google Scholar
• Padhani DH, Maji KP, Mtanda AT. Ocular manifestations in children with HIV infection in Dar es Salaam, Tanzania. J Trop Pediatr. 2000;46(3):145–148. doi:10.1093/tropej/46.3.145.
   PubMed Web of Science ®Google Scholar
• Livingston PG, Kerr NC, Sullivan JL. Ocular disease in children with vertically acquired human immunodeficiency virus infection. J Aapos. 1998;2(3):177–181. doi:10.1016/S1091-8531(98)90010-6.
   PubMedGoogle Scholar
• Ikoona E, Kalyesubula I, Kawuma M. Ocular manifestations in paediatric HIV/AIDS patients in Mulago Hospital, Uganda. Afr Health Sci. 2003;3:83–86.
   PubMedGoogle Scholar
• Biswas J, Saha I, Das I, Bandyopadhyay S, Ray R, Biswas G. Ocular morbidity among children at a tertiary eye care hospital in Kolkata, West Bengal. Indian J Public Health. 2012;56(4):293–296. doi:10.4103/0019-557X.106418.
   PubMedGoogle Scholar